Robey Robert W, Steadman Kenneth, Polgar Orsolya, Morisaki Kuniaki, Blayney Margaret, Mistry Prakash, Bates Susan E
Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Rm. 12C203, 9000 Rockville Pike, Bethesda, MD 20892, USA.
Cancer Res. 2004 Feb 15;64(4):1242-6. doi: 10.1158/0008-5472.can-03-3298.
Pheophorbide a (PhA), a chlorophyll catabolite, was shown to be an ABCG2 substrate based on Abcg2(-/-) knockout mouse studies (J. W. Jonker et al., Proc. Natl. Acad. Sci. USA, 99: 15649-15654, 2002). We developed a functional assay for ABCG2 using PhA and the ABCG2 inhibitor fumitremorgin C. In selected cell lines expressing high levels of P-glycoprotein, multidrug resistance-associated protein 1, or ABCG2, PhA transport was observed only in cells expressing ABCG2. Fumitremorgin C-inhibitable PhA transport was found to correlate with cell surface ABCG2 expression as measured by the anti-ABCG2 antibody 5D3. We found that 100 micro M of the cyclin-dependent kinase inhibitor UCN-01 or 1 micro M of the P-glycoprotein inhibitor tariquidar inhibited ABCG2-mediated PhA transport. In 4-day cytotoxicity assays, ABCG2-mediated resistance to SN-38 and topotecan was abrogated in ABCG2-transfected HEK-293 cells treated with 1 micro M tariquidar, and ABCG2-transfected cells were 6-7-fold resistant to UCN-01. PhA is an ABCG2-specific substrate with potential value in measuring ABCG2 function and expression in clinical samples.
基于对Abcg2(-/-)基因敲除小鼠的研究(J. W. 容克等人,《美国国家科学院院刊》,99: 15649 - 15654, 2002),脱镁叶绿酸a(PhA),一种叶绿素分解代谢产物,被证明是ABCG2的底物。我们使用PhA和ABCG2抑制剂烟曲霉毒素C开发了一种用于ABCG2的功能测定方法。在选定的高表达P-糖蛋白、多药耐药相关蛋白1或ABCG2的细胞系中,仅在表达ABCG2的细胞中观察到PhA转运。发现烟曲霉毒素C可抑制的PhA转运与用抗ABCG2抗体5D3测量的细胞表面ABCG2表达相关。我们发现100 μM的细胞周期蛋白依赖性激酶抑制剂UCN - 01或1 μM的P-糖蛋白抑制剂他林洛尔可抑制ABCG2介导的PhA转运。在为期4天的细胞毒性试验中,在用1 μM他林洛尔处理的ABCG2转染的HEK - 293细胞中,ABCG2介导的对SN - 38和拓扑替康的耐药性被消除,并且ABCG2转染的细胞对UCN - 01有6 - 7倍的耐药性。PhA是一种ABCG2特异性底物,在测量临床样本中ABCG2的功能和表达方面具有潜在价值。